Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Implications of CMR Low Native T1 in Non-treated Non-hypertrophic Females With a Genetically Confirmed Diagnosis of Fabry Disease (FD)

NCT07872852 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT07872852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07872852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Implications of CMR Low Native T1 in Non-treated Non-hypertrophic Females With a Genetically Confirmed Diagnosis of Fabry Disease (FD)
Lead sponsor
University Hospital, Bordeaux
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
May 1, 2033
Enrollment
60 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

fabry disease